NEOADJUVANT ANDROGEN ABLATION FOR LOCALIZED PROSTATIC CANCER: PATHOLOGY METHODS, SURGICAL END POINTS AND META-ANALYSIS OF RANDOMIZED TRIALS-Reference-Cited by-同舟云学术

NEOADJUVANT ANDROGEN ABLATION FOR LOCALIZED PROSTATIC CANCER: PATHOLOGY METHODS, SURGICAL END POINTS AND META-ANALYSIS OF RANDOMIZED TRIALS

Published:1998-11 Issue:5 Volume:160 Page:1754-1760
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

BONNEY WILLIAM W.¹,SCHNED ALAN R.¹,TIMBERLAKE DAVID S.¹

Affiliation:

1. From the Surgery Department (Urology), Dartmouth Medical School, Hanover and Pathology Department, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, and Family and Preventive Medicine, University of California at San Diego, San Diego, California

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference29 articles.

1. An evaluation of endocrine control therapy plus radical perineal prostatectomy in the treatment of selected cases of advanced carcinoma of the prostate followed five or more years;Scott;J. Urol.,1957

2. Non-resectable carcinoma of the prostate rendered resectable by endocrine therapy;Chute;J. Urol.,1966

3. Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer;Goldenberg;J. Urol.,1996

4. Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer;Soloway;J. Urol.,1995

5. Neoadjuvant hormonal therapy before radical prostatectomy decreases the number of positive surgical margins in stage T2 prostate cancer: interim results of a prospective randomized trial;van Poppel;J. Urol.,1995

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neo-adjuvant hormone therapy for non-metastatic prostate cancer: a systematic review and meta-analysis of 5,194 patients;World Journal of Surgical Oncology;2015-02-22

2. Picking the Optimal Duration of Hormonal Therapy in Men With High-Risk and Locally Advanced Prostate Cancer Treated With Radiotherapy;Seminars in Radiation Oncology;2013-07

3. Prostatakarzinom;Strahlentherapie;2013

4. Effect of neoadjuvant epirubicin and total androgen blockade on complete pathological response in patients with clinical stage T3/T4 prostate cancer;European Journal of Surgical Oncology (EJSO);2008-02

5. Update in systemic therapy of prostate cancer: improvement in quality and duration of life;Expert Review of Anticancer Therapy;2008-02